4.6 Review

Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases

Journal

PHARMACEUTICALS
Volume 2, Issue 3, Pages 194-205

Publisher

MDPI
DOI: 10.3390/ph2030194

Keywords

resveratrol; Alzheimer's disease; Parkinson's disease; SIRT1

Funding

  1. Ministerio de Educacion y Ciencia [SAF-2009-13093]
  2. Instituto de Salud Carlos III [PI080400]
  3. Generalitat de Catalunya [2009/SGR00853]
  4. Fundacio La Marato de TV3 [063230]
  5. Agencia Espanola de Cooperacion Internacional para el Desarrollo AECID [B/016995/08]
  6. 'Beatriu de Pinos' postdoctoral contract - 'Generalitat de Catalunya'

Ask authors/readers for more resources

The prevention of aging is one of the most fascinating areas in biomedicine. The first step in the development of effective drugs for aging prevention is a knowledge of the biochemical pathways responsible for the cellular aging process. In this context it seems clear that free radicals play a key role in the aging process. However, in recent years it has been demonstrated that the families of enzymes called sirtuins, specifically situin 1 (SIRT1), have an anti-aging action. Thus, the natural compound resveratrol is a natural compound that shows a very strong activation of SIRT1 and also shows antioxidant effects. By activating sirtuin 1, resveratrol modulates the activity of numerous proteins, including peroxisome proliferator-activated receptor coactivator-1 alpha (PGC-1 alpha), the FOXO family, Akt (protein kinase B) and NF kappa beta. In the present review, we suggest that resveratrol may constitute a potential drug for prevention of ageing and for the treatment of several diseases due to its antioxidant properties and sirtuin activation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available